查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
镰状细胞病治疗市场与 COVID-19 影响分析，按疾病、治疗、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1335286

镰状细胞病治疗市场与 COVID-19 影响分析，按疾病、治疗、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Sickle Cell Disease Treatment Market with COVID-19 Impact Analysis, By Disease, By Treatment, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年镰状细胞病治疗市场规模为 10.107 亿美元，2023 年至 2030 年復合年增长率为 30.8%。

镰状细胞病治疗市场-市场动态：

  • 新型药物的创新推动了市场的增长。
  • 英国发现了 20 年来首个治疗镰状细胞病的新疗法。 Crizanlizumab 是诺华公司生产的一种药物，被称为“一种创新疗法”。据英国广播公司报导，它被注射到静脉中，可以单独使用，也可以与定期输血和常规医疗护理结合使用。在一项研究中，使用 crizanlizumab 的患者平均每年经历 1.6 次镰状细胞危象，低于正常情况下每年近 3 次。一种名为 crizanlizumab 的药物用于降低 16 岁及以上镰状细胞性贫血患者血管闭塞危象的发生率。由于这些创造性的突破性治疗，镰状细胞病治疗市场正在扩大。

镰状细胞病治疗市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，预计全球镰状细胞病治疗市场在预测期内（2023-2030）每年将以 30.8% 左右的复合年增长率增长
  • 由于镰状细胞贫血病的高发病率，镰状细胞病治疗行业预计将以显着的速度增长
  • 根据该疾病，镰状细胞贫血症预计在预测期内将以最高复合年增长率增长
  • 根据治疗方法，输血领域预计将在预测期内占据最大的市场份额
  • 从地区来看，预计北美将在预测期内主导市场

镰状细胞病治疗市场-細項分析：

  • 全球镰状细胞病治疗市场根据疾病、治疗和区域进行细分。
  • 根据疾病，全球镰状细胞病治疗市场分为镰状细胞贫血症、镰状血红蛋白c病、镰状β地中海贫血等。镰状细胞贫血症领域预计在预测期内将以最高的复合年增长率增长。这种扩张是由于基因突变导致镰状细胞性贫血患者数量增加的结果。 11 号染色体上发现的血红蛋白-β 基因突变会导致镰状细胞病。由于血红蛋白缺陷，镰状细胞性贫血中的红细胞坚硬、粘稠且畸形。遗传性镰状细胞性贫血的流行正在加速这个市场的扩张。
  • 根据治疗，全球市场分为输血、药物治疗、骨髓移植。预计输血领域将在预测期内占据最大的市场份额。镰状细胞病治疗中大量使用输血是这一上升的原因。急性胸部综合征 (ACS) 可通过简单的浓缩红细胞输注 (ST) 和自动红细胞交换 (RCE) 进行治疗。镰状细胞病患者通常患有中风，越来越多地使用输血来治疗中风，这推动了该市场的扩张。

镰状细胞病治疗市场-地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美将在预测期内主导市场。该地区市场收入的增长主要得益于镰状细胞病治疗的重大进步和治疗方案的广泛普及。该地区高水平的可支配收入也是市场收入扩大的主要推动力。由于政府援助不断增加，美国市场的收入份额最高。此外，当地市场参与者正在联手进行收购，以使其产品多样化并建立全球影响力。例如，2022 年，辉瑞公司 (Pfizer Inc.) 和 Global Blood Therapeutics, Inc. 达成一项协议，最终将增加血液学产品组合。

镰状细胞病治疗市场-竞争格局：

该市场的主要参与者包括Medunik USA、Bristol Myers Squibb Co.、Emmaus Medical Inc.、Addmedica、Novartis AG、Global Blood Therapeutics Inc.、Sanofi SA、Bluebird Biotechnology、Pfizer Inc.、Aruvant Sciences Inc.、Glycomimetics Inc. 。 、Editas Medicine Inc. 和 CRISPR Therapeutic。

最近的发展：

2022 年 2 月，Global Blood Therapeutics Inc. 获准销售 Oxbryta，用于治疗成人和 12 岁及以上儿童的镰状细胞病 (SCD) 相关溶血性贫血，作为单一疗法或与羟基脲联合治疗。

该研究的主要特点：

  • 这项关于镰状细胞病治疗市场的拟议研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030），以 2022 年为基准年
  • 该报告为客户提供有关镰状细胞病治疗市场的最新趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了镰状细胞病治疗市场有吸引力的投资主张矩阵
  • 总体报告确定了镰状细胞病治疗市场的新投资机会、现有参与者面临的挑战以及维持镰状细胞病治疗市场的增长因素
  • COVID-19 对镰状细胞病治疗市场规模、预测、复合年增长率和市场动态的影响将在研究范围下详细讨论。还将详细介绍新冠疫情后镰状细胞病治疗市场的情况。
  • 为了让本报告的用户全面了解镰状细胞病治疗市场，我们还包括镰状细胞病治疗市场的竞争格局和关键创新者分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这将帮助用户了解镰状细胞病治疗市场参与者的财务信息和战略倡议。
  • 此外，报告还公布了全球和区域市场主要参与者的重要收购和合併、合作和合资、新产品推出、研发、区域扩张。
  • 全球镰状细胞病治疗市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师

目录

第一章：镰状细胞病治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按疾病分類的镰状细胞病治疗市场片段
    • 镰状细胞病治疗市场片段（按治疗）
    • 按国家/地区分類的镰状细胞病治疗市场片段
    • 按地区分類的镰状细胞病治疗市场片段
  • 竞争洞察

第 3 章：镰状细胞病治疗主要市场趋势

  • 镰状细胞病治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 镰状细胞病治疗市场限制
    • 市场限制影响分析
  • 镰状细胞病治疗市场机会
  • 镰状细胞病治疗市场未来趋势

第 4 章：镰状细胞病治疗行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：镰状细胞病治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：镰状细胞病治疗市场格局

  • 2022 年镰状细胞病治疗市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：镰状细胞病治疗市场 - 按疾病分类

  • 概述
    • 按疾病分類的细分市场份额分析
    • 镰状细胞性贫血
    • 镰状血红蛋白C病
    • 镰状β地中海贫血
    • 其他的

第 8 章：镰状细胞病治疗市场 - 按治疗分类

  • 概述
    • 按处理方式分類的细分市场份额分析
    • 输血
    • 药物治疗
    • 骨髓移植

第 9 章：镰状细胞病治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • 北美镰状细胞病治疗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疾病）
    • 北美市场规模和预测（按不同处理方式）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲镰状细胞病治疗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按疾病）
    • 欧洲市场规模和预测（按处理方式）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区镰状细胞病治疗主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按疾病）
    • 亚太地区市场规模和预测（按不同处理方式）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • 拉丁美洲镰状细胞病治疗主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按疾病）
    • 拉丁美洲市场规模和预测（按不同处理方式）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲镰状细胞病治疗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疾病）
    • 中东和非洲市场规模及预测（按不同处理方式）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 10 章：主要供应商分析 - 镰状细胞病治疗行业

  • 竞争仪表板
  • 公司简介
    • Medunik USA
    • Bristol Myers Squibb Co.
    • Emmaus Medical Inc.
    • Addmedica
    • Novartis AG
    • Global Blood Therapeutics Inc.
    • Sanofi SA
    • Bluebird Biotechnology
    • Pfizer Inc.
    • Aruvant Sciences Inc.
    • Glycomimetics Inc.
    • Editas Medicine Inc.
    • CRISPR Therapeutic

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1577

REPORT HIGHLIGHT

Sickle Cell Disease Treatment Market size was valued at USD 1,010.7 Million in 2022, expanding at a CAGR of 30.8% from 2023 to 2030.

Hemoglobin, a protein that transports oxygen throughout the body, is impacted by sickle cell disease (SCD), a hereditary red blood cell (RBC) problem. Numerous consequences are brought on by it, including acute chest syndrome, anemia, and vaso-occlusive crisis (VOC). Currently, doctors frequently recommend bone marrow and blood transplants to treat SCD. It entails removing the damaged bone marrow and replacing it with healthy bone marrow obtained from a donor. As they can lessen particular symptoms and extend patients' lives, other efficient therapies including pharmaceuticals and blood transfusions are also being used.

Sickle Cell Disease Treatment Market- Market Dynamics:

  • Innovation in novel medication drives the market growth.
  • The first new treatment for sickle cell disease in 20 years has been discovered in the United Kingdom. Crizanlizumab, a drug produced by Novartis, has been referred to be "an innovative treatment." According to the BBC, it is injected into a vein and can be used alone or in conjunction with regular blood transfusions and conventional medical care. In a study, patients using crizanlizumab experienced a sickle-cell crisis 1.6 times year on average, down from nearly three times annually in the norm. A drug called crizanlizumab is used to reduce the incidence of vaso-occlusive crises in sickle cell anemia patients aged 16 and older. The Sickle Cell Disease Treatment Market is expanding as a result of these inventive breakthrough treatments.

Sickle Cell Disease Treatment Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Sickle Cell Disease Treatment market is estimated to grow annually at a CAGR of around 30.8% over the forecast period (2023-2030)
  • The Sickle Cell Disease Treatment industry is projected to grow at a significant rate owing to the high incidence of sickle cell anemia disease
  • Based on the disease, the sickle cell anaemia segment is expected to grow at the highest CAGR over the forecast period
  • Based on the treatment, the blood transfusion segment is expected to capture the largest market share over the forecast period
  • Based on region, North America is expected to dominate the market over the forecast period

Sickle Cell Disease Treatment Market- Segmentation Analysis:

  • The Global Sickle Cell Disease Treatment Market is segmented based on disease, treatment, and Region.
  • Based on disease, the global Sickle Cell Disease Treatment market is segmented into sickle cell anaemia, sickle haemoglobin c disease, sickle beta thalassemia, others. The sickle cell anaemia segment is expected to grow at the highest CAGR over the forecast period. This expansion is the result of an increase in sickle cell anemia patients brought on by a gene mutation. A mutation in the haemoglobin-Beta gene found on chromosome 11 causes sickle cell disease. Red blood cells in sickle cell anemia are hard, sticky, and malformed as a result of the defective hemoglobin. The prevalence of inheriting sickle cell anemia is accelerating this market's expansion.
  • Based on treatment, the global market is segmented into blood transfusion, pharmacotherapy, bone marrow transplant. The blood transfusion segment is expected to capture the largest market share over the forecast period. The massive use of blood transfusion in the treatment of sickle cell disease is the cause of this rise. Acute chest syndrome (ACS) is treated with both simple transfusion (ST) of packed red blood cells and automated red cell exchange (RCE). The increasing use of blood transfusions in the treatment of stroke, which sickle cell disease patients commonly have, is fueling this market's expansion.

Sickle Cell Disease Treatment Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The region's market revenue growth is primarily being driven by significant advancements in the treatment of sickle cell disease and widespread accessibility to treatment options. The high level of disposable income in this region is also a major driver of the expansion of market revenue. The highest revenue share came from the U.S. market as a result of rising government assistance. Additionally, local market players are joining forces and making acquisitions to diversify their product offerings and establish a worldwide presence. For instance, in 2022, Pfizer Inc. and Global Blood Therapeutics, Inc. reached a deal that will ultimately increase the hematology product portfolio.

Sickle Cell Disease Treatment Market- Competitive Landscape:

The key players operating in the market are Medunik USA, Bristol Myers Squibb Co., Emmaus Medical Inc., Addmedica, Novartis AG, Global Blood Therapeutics Inc, Sanofi SA, Bluebird Biotechnology, Pfizer Inc., Aruvant Sciences Inc., Glycomimetics Inc., Editas Medicine Inc. and CRISPR Therapeutic.

Recent Developments:

In February 2022, Global Blood Therapeutics Inc. was granted permission to sell Oxbryta for the treatment of sickle cell disease (SCD)-related hemolytic anemia in adults and children 12 years of age and older as a monotherapy or in combination with hydroxycarbamide.

Key features of the study:

  • This proposed research study on Sickle Cell Disease Treatment market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Sickle Cell Disease Treatment market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Sickle Cell Disease Treatment market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Sickle Cell Disease Treatment market
  • Impact of COVID-19 on Sickle Cell Disease Treatment market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Sickle Cell Disease Treatment market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Sickle Cell Disease Treatment market, we have also included competitive landscape and key innovator analysis for the Sickle Cell Disease Treatment market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Sickle Cell Disease Treatment market.
  • In addition, the report also unveils the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Sickle Cell Disease Treatment market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SICKLE CELL DISEASE TREATMENT MARKET KEY PLAYERS

  • Medunik USA
  • Bristol Myers Squibb Co.
  • Emmaus Medical Inc.
  • Addmedica
  • Novartis AG
  • Global Blood Therapeutics Inc.
  • Sanofi SA
  • Bluebird Biotechnology
  • Pfizer Inc.
  • Aruvant Sciences Inc.
  • Glycomimetics Inc.
  • Editas Medicine Inc.
  • CRISPR Therapeutic

GLOBAL SICKLE CELL DISEASE TREATMENT MARKET, BY DISEASE

  • Sickle Cell Anaemia
  • Sickle Haemoglobin C Disease
  • Sickle Beta Thalassemia
  • Others

GLOBAL SICKLE CELL DISEASE TREATMENT MARKET, BY TREATMENT

  • Blood Transfusion
  • Pharmacotherapy
  • Bone Marrow Transplant

GLOBAL SICKLE CELL DISEASE TREATMENT MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Sickle Cell Disease Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Sickle Cell Disease Treatment Market Snippet by Disease
    • 2.1.2. Sickle Cell Disease Treatment Market Snippet by Treatment
    • 2.1.3. Sickle Cell Disease Treatment Market Snippet by Country
    • 2.1.4. Sickle Cell Disease Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Sickle Cell Disease Treatment Key Market Trends

  • 3.1. Sickle Cell Disease Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Sickle Cell Disease Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Sickle Cell Disease Treatment Market Opportunities
  • 3.4. Sickle Cell Disease Treatment Market Future Trends

4. Sickle Cell Disease Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Sickle Cell Disease Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Sickle Cell Disease Treatment Market Landscape

  • 6.1. Sickle Cell Disease Treatment Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Sickle Cell Disease Treatment Market - By Disease

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease, 2022 & 2030 (%)
    • 7.1.2. Sickle Cell Anaemia
    • 7.1.3. Sickle Haemoglobin C Disease
    • 7.1.4. Sickle Beta Thalassemia
    • 7.1.5. Others

8. Sickle Cell Disease Treatment Market - By Treatment

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Treatment, 2022 & 2030 (%)
    • 8.1.2. Blood Transfusion
    • 8.1.3. Pharmacotherapy
    • 8.1.4. Bone Marrow Transplant

9. Sickle Cell Disease Treatment Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Sickle Cell Disease Treatment Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Sickle Cell Disease Treatment Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Sickle Cell Disease Treatment Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Sickle Cell Disease Treatment Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Sickle Cell Disease Treatment Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Disease, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Treatment, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Sickle Cell Disease Treatment Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Medunik USA
    • 10.2.2. Bristol Myers Squibb Co.
    • 10.2.3. Emmaus Medical Inc.
    • 10.2.4. Addmedica
    • 10.2.5. Novartis AG
    • 10.2.6. Global Blood Therapeutics Inc.
    • 10.2.7. Sanofi SA
    • 10.2.8. Bluebird Biotechnology
    • 10.2.9. Pfizer Inc.
    • 10.2.10. Aruvant Sciences Inc.
    • 10.2.11. Glycomimetics Inc.
    • 10.2.12. Editas Medicine Inc.
    • 10.2.13. CRISPR Therapeutic

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Sickle Cell Disease Treatment Market: Disease Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Sickle Cell Disease Treatment Market, by Disease 2018-2030 (USD Million)
  • TABLE Sickle Cell Disease Treatment Market: Treatment Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Treatment
  • TABLE Global Sickle Cell Disease Treatment Market, by Treatment 2018-2030 (USD Million)
  • TABLE Sickle Cell Disease Treatment Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Sickle Cell Disease Treatment Market, by Region 2018-2030 (USD Million)
  • TABLE North America Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE North America Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Europe Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE Europe Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE Asia Pacific Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Latin America Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE Latin America Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sickle Cell Disease Treatment Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sickle Cell Disease Treatment Market, by Disease, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Sickle Cell Disease Treatment Market, by Treatment, 2018-2030 (USD Million)